Campbell & Co Investment Adviser’s Medpace MEDP Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,457	Closed	-$9.24M	–	1275
2025 Q4	$9.24M	Buy	+16,457	New	+$9.34M	0.44%	22
2025 Q3	–	Sell	-3,374	Closed	-$1.06M	–	1275
2025 Q2	$1.06M	Buy	+3,374	New	+$1.01M	0.07%	479
2024 Q4	–	Sell	-2,591	Closed	-$865K	–	1236
2024 Q3	$865K	Buy	+2,591	New	+$984K	0.06%	492
2024 Q2	–	Sell	-8,448	Closed	-$3.41M	–	1234
2024 Q1	$3.41M	Sell	8,448 -9,264	-52%	-$3.26M	0.29%	44
2023 Q4	$5.43M	Buy	+17,712	New	+$4.78M	0.49%	6
2023 Q3	–	Sell	-2,730	Closed	-$656K	–	1096
2023 Q2	$656K	Buy	2,730 +658	+32%	+$137K	0.12%	302
2023 Q1	$390K	Sell	2,072 -241	-10%	-$49.8K	0.07%	511
2022 Q4	$491K	Buy	+2,313	New	+$462K	0.12%	324

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Campbell & Co Investment Adviser's MEDP Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Medpace (MEDP) in Q1 2026, closing a stake of 16,457 shares — an estimated $9.24M sold.

Campbell & Co Investment Adviser first reported a position in MEDP in Q4 2022 and held it in 8 quarters. The position peaked at $9.24M in Q4 2025. 734 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Campbell & Co Investment Adviser reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 16,457 Medpace shares in Q1 2026, an estimated $9.24M.
Campbell & Co Investment Adviser first reported a position in Medpace in Q4 2022 and held it in 8 quarters.
Campbell & Co Investment Adviser's Medpace position peaked at $9.24M in Q4 2025.
734 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.